ID

23600

Beschrijving

Responsible Party: Saarland University ClinicalTrials.gov Identifier: NCT02905539 History of Changes Other Study ID Numbers: P-0101 2015-004808-36 ( EudraCT Number ) U1111-1176-4563 ( Registry Identifier: WHO Universal Trial Number ) DRKS00010766 ( Registry Identifier: Deutsches Register Klinischer Studien ) Study First Received: September 8, 2016 Last Updated: September 13, 2016 A Study Comparing the Iron Substitution With the Medicinal Products Ferinject or Monofer (HOMe_aFers_1) ODM derived from: https://clinicaltrials.gov/ct2/show/NCT02905539

Link

https://clinicaltrials.gov/ct2/show/NCT02905539

Trefwoorden

  1. 09-07-17 09-07-17 -
  2. 28-12-17 28-12-17 -
  3. 20-09-21 20-09-21 -
Geüploaded op

9 juli 2017

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY-NC-ND 3.0

Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility Anemia NCT02905539 DRKS00010766

Eligibility Anemia NCT02905539 DRKS00010766

Inclusion Criteria
Beschrijving

Inclusion Criteria

Alias
UMLS CUI-1
C1512693
Written informed consent,
Beschrijving

Informed Consent

Datatype

boolean

Alias
UMLS CUI [1]
C0021430
Female,
Beschrijving

Gender

Datatype

boolean

Alias
UMLS CUI [1]
C0079399
Gynecological blood losses,
Beschrijving

Gynecological blood losses

Datatype

boolean

Alias
UMLS CUI [1,1]
C0018417
UMLS CUI [1,2]
C3163616
Age ≥ 18 years,
Beschrijving

Age

Datatype

boolean

Iron deficiency anemia,
Beschrijving

Iron deficiency anemia

Datatype

boolean

Alias
UMLS CUI [1]
C0162316
Hemoglobin < 12,0 g/dl,
Beschrijving

Hemoglobin

Datatype

boolean

Alias
UMLS CUI [1]
C0019046
Serum-Ferritin ≤ 100 ng/ml or Serum-Ferritin ≤ 300 ng/ml and Transferrin-saturation ≤ 30 %,
Beschrijving

Serum-Ferritin, Transferrin-saturation

Datatype

boolean

Alias
UMLS CUI [1]
C0696113
UMLS CUI [2]
C1277709
Intolerance to or inefficacy of an oral iron supplement
Beschrijving

Intolerance to oral iron supplement

Datatype

boolean

Alias
UMLS CUI [1,1]
C0721124
UMLS CUI [1,2]
C1744706
Estimated Glomerular Filtration Rate > 15 ml/min/1.73 m²
Beschrijving

Glomerular Filtration Rate

Datatype

boolean

Alias
UMLS CUI [1]
C0017654
Exclusion Criteria
Beschrijving

Exclusion Criteria

Alias
UMLS CUI-1
C0680251
Healthy Volunteers
Beschrijving

Control Group

Datatype

boolean

Alias
UMLS CUI [1]
C0009932
Known hypersensitivity to MonoFer® or FERINJECT®,
Beschrijving

Hypersensitivity to iron supplement

Datatype

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0721124
Severe, known hypersensitivity to other intravenous iron preparations,
Beschrijving

Hypersensitivity

Datatype

boolean

Alias
UMLS CUI [1]
C0020517
Plasma Phosphate < 2.5 mg/dl at screening,
Beschrijving

Plasma Phosphate

Datatype

boolean

Alias
UMLS CUI [1]
C1276038
Hemochromatosis,
Beschrijving

Hemochromatosis

Datatype

boolean

Alias
UMLS CUI [1]
C0018995
Untreated hyperparathyroidism,
Beschrijving

Hyperparathyroidism

Datatype

boolean

Alias
UMLS CUI [1]
C0020502
Renal replacement therapy/kidney transplantation,
Beschrijving

Renal replacement therapy, Kidney transplantation

Datatype

boolean

Alias
UMLS CUI [1]
C0206074
UMLS CUI [2]
C0022671
Active malignant disease, disease-free survival for less than 5 years,
Beschrijving

Malignancy

Datatype

boolean

Alias
UMLS CUI [1]
C0006826
Intravenous iron administration within the last 30 days,
Beschrijving

Intravenous iron administration

Datatype

boolean

Alias
UMLS CUI [1,1]
C0013125
UMLS CUI [1,2]
C0721124
Treatment with erythropoietin or erythropoietin-stimulating agents, transfusion of red blood cells, radiotherapy or chemotherapy within the last 60 days,
Beschrijving

Treatment

Datatype

boolean

Alias
UMLS CUI [1]
C0087111
Surgery under anesthetic within the last 10 days,
Beschrijving

Surgery

Datatype

boolean

Alias
UMLS CUI [1]
C0543467
Alanine transaminase (ALT) or aspartate transaminase (AST) > 1.5 fold above levels in healthy individuals,
Beschrijving

ALT, AST

Datatype

boolean

Alias
UMLS CUI [1]
C0201836
UMLS CUI [2]
C0201899
Acute febrile infections within the last 7 days,
Beschrijving

Febrile infection

Datatype

boolean

Alias
UMLS CUI [1]
C0948233
Chronic inflammatory diseases requiring a systemic antiinflammatory treatment,
Beschrijving

Chronic inflammatory diseases

Datatype

boolean

Alias
UMLS CUI [1]
C1290886
self-reported severe asthma or eczema,
Beschrijving

Asthma or eczema

Datatype

boolean

Alias
UMLS CUI [1]
C0004096
UMLS CUI [2]
C0013595
Presence of relative contraindications (any allergy, any immunologic or inflammatory disease, history of atopic allergies), for which a treatment with the medicinal investigational products is not deemed indicated by the investigator,
Beschrijving

Contraindication

Datatype

boolean

Alias
UMLS CUI [1]
C1301624
Pregnancy,
Beschrijving

Pregnancy

Datatype

boolean

Alias
UMLS CUI [1]
C0032961
Women of childbearing potential without an effective method of contraception,
Beschrijving

Contraceptive Methods

Datatype

boolean

Alias
UMLS CUI [1]
C0700589
Lactating women,
Beschrijving

Lactating

Datatype

boolean

Alias
UMLS CUI [1]
C2828358
Present alcohol or drug dependency,
Beschrijving

Substance Use Disorder

Datatype

boolean

Alias
UMLS CUI [1]
C0038586
Patients with a history of a psychological illness or seizures,
Beschrijving

Mental disorder, Seizures

Datatype

boolean

Alias
UMLS CUI [1]
C0004936
UMLS CUI [2]
C0036572
Non-compliance or administration of any investigational drug within 30 days preceding the study start.
Beschrijving

Compliance

Datatype

boolean

Alias
UMLS CUI [1]
C1321605

Similar models

Eligibility Anemia NCT02905539 DRKS00010766

Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
Inclusion Criteria
C1512693 (UMLS CUI-1)
Informed Consent
Item
Written informed consent,
boolean
C0021430 (UMLS CUI [1])
Gender
Item
Female,
boolean
C0079399 (UMLS CUI [1])
Gynecological blood losses
Item
Gynecological blood losses,
boolean
C0018417 (UMLS CUI [1,1])
C3163616 (UMLS CUI [1,2])
Age
Item
Age ≥ 18 years,
boolean
Iron deficiency anemia
Item
Iron deficiency anemia,
boolean
C0162316 (UMLS CUI [1])
Hemoglobin
Item
Hemoglobin < 12,0 g/dl,
boolean
C0019046 (UMLS CUI [1])
Serum-Ferritin, Transferrin-saturation
Item
Serum-Ferritin ≤ 100 ng/ml or Serum-Ferritin ≤ 300 ng/ml and Transferrin-saturation ≤ 30 %,
boolean
C0696113 (UMLS CUI [1])
C1277709 (UMLS CUI [2])
Intolerance to oral iron supplement
Item
Intolerance to or inefficacy of an oral iron supplement
boolean
C0721124 (UMLS CUI [1,1])
C1744706 (UMLS CUI [1,2])
Glomerular Filtration Rate
Item
Estimated Glomerular Filtration Rate > 15 ml/min/1.73 m²
boolean
C0017654 (UMLS CUI [1])
Item Group
Exclusion Criteria
C0680251 (UMLS CUI-1)
Control Group
Item
Healthy Volunteers
boolean
C0009932 (UMLS CUI [1])
Hypersensitivity to iron supplement
Item
Known hypersensitivity to MonoFer® or FERINJECT®,
boolean
C0020517 (UMLS CUI [1,1])
C0721124 (UMLS CUI [1,2])
Hypersensitivity
Item
Severe, known hypersensitivity to other intravenous iron preparations,
boolean
C0020517 (UMLS CUI [1])
Plasma Phosphate
Item
Plasma Phosphate < 2.5 mg/dl at screening,
boolean
C1276038 (UMLS CUI [1])
Hemochromatosis
Item
Hemochromatosis,
boolean
C0018995 (UMLS CUI [1])
Hyperparathyroidism
Item
Untreated hyperparathyroidism,
boolean
C0020502 (UMLS CUI [1])
Renal replacement therapy, Kidney transplantation
Item
Renal replacement therapy/kidney transplantation,
boolean
C0206074 (UMLS CUI [1])
C0022671 (UMLS CUI [2])
Malignancy
Item
Active malignant disease, disease-free survival for less than 5 years,
boolean
C0006826 (UMLS CUI [1])
Intravenous iron administration
Item
Intravenous iron administration within the last 30 days,
boolean
C0013125 (UMLS CUI [1,1])
C0721124 (UMLS CUI [1,2])
Treatment
Item
Treatment with erythropoietin or erythropoietin-stimulating agents, transfusion of red blood cells, radiotherapy or chemotherapy within the last 60 days,
boolean
C0087111 (UMLS CUI [1])
Surgery
Item
Surgery under anesthetic within the last 10 days,
boolean
C0543467 (UMLS CUI [1])
ALT, AST
Item
Alanine transaminase (ALT) or aspartate transaminase (AST) > 1.5 fold above levels in healthy individuals,
boolean
C0201836 (UMLS CUI [1])
C0201899 (UMLS CUI [2])
Febrile infection
Item
Acute febrile infections within the last 7 days,
boolean
C0948233 (UMLS CUI [1])
Chronic inflammatory diseases
Item
Chronic inflammatory diseases requiring a systemic antiinflammatory treatment,
boolean
C1290886 (UMLS CUI [1])
Asthma or eczema
Item
self-reported severe asthma or eczema,
boolean
C0004096 (UMLS CUI [1])
C0013595 (UMLS CUI [2])
Contraindication
Item
Presence of relative contraindications (any allergy, any immunologic or inflammatory disease, history of atopic allergies), for which a treatment with the medicinal investigational products is not deemed indicated by the investigator,
boolean
C1301624 (UMLS CUI [1])
Pregnancy
Item
Pregnancy,
boolean
C0032961 (UMLS CUI [1])
Contraceptive Methods
Item
Women of childbearing potential without an effective method of contraception,
boolean
C0700589 (UMLS CUI [1])
Lactating
Item
Lactating women,
boolean
C2828358 (UMLS CUI [1])
Substance Use Disorder
Item
Present alcohol or drug dependency,
boolean
C0038586 (UMLS CUI [1])
Mental disorder, Seizures
Item
Patients with a history of a psychological illness or seizures,
boolean
C0004936 (UMLS CUI [1])
C0036572 (UMLS CUI [2])
Compliance
Item
Non-compliance or administration of any investigational drug within 30 days preceding the study start.
boolean
C1321605 (UMLS CUI [1])

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial